OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer
Xiaomeng Xie(Zhengzhou University), Dong Joon Kim(Hallym University)
Cited by 18
Related Papers
2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
|Journal of Experimental & Clinical Cancer Research|2020|21
Identification of sinensetin as a selective inhibitor for mitogen-activated protein kinase kinase 6 and an anticancer agent for non-small cell lung cancer
|American Journal of Cancer Research|2025|1